MARKET

PETQ

PETQ

PetIQ
NASDAQ

Real-time Quotes | Nasdaq Last Sale

35.83
+0.93
+2.66%
Closed 16:00 07/02 EDT
OPEN
35.67
PREV CLOSE
34.90
HIGH
36.34
LOW
35.26
VOLUME
306.87K
TURNOVER
--
52 WEEK HIGH
36.34
52 WEEK LOW
15.83
MARKET CAP
1.02B
P/E (TTM)
-55.5590
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average PETQ stock price target is 41.80 with a high estimate of 50.00 and a low estimate of 35.00.

EPS

PETQ News

More
Raymond James Reiterates Outperform on PetIQ, Raises Price Target to $41
Raymond James reiterates PetIQ (NASDAQ:PETQ) with a Outperform and raises the price target from $35 to $41.
Benzinga · 5d ago
Guggenheim Maintains Buy on PetIQ, Raises Price Target to $44
Guggenheim analyst David Westenberg maintains PetIQ (NASDAQ:PETQ) with a Buy and raises the price target from $33.5 to $44.
Benzinga · 06/25 11:14
PetIQ, Inc. to Participate in the Jefferies Virtual Consumer Conference
GlobeNewswire · 06/16 13:00
Raymond James Maintains Outperform on PetIQ, Raises Price Target to $35
Raymond James maintains PetIQ (NASDAQ:PETQ) with a Outperform and raises the price target from $32 to $35.
Benzinga · 06/16 11:32
PetIQ, Inc. to Participate in the 40th Annual William Blair Growth Stock Conference
GlobeNewswire · 06/03 13:00
7 Perfect 10 Stocks to Buy Now
TipRanks · 05/25 15:00
PetIQ (PETQ) Catches Eye: Stock Jumps 8.4%
Zacks · 05/18 13:31
PetIQ prices $125M convertible senior notes offering
Seeking Alpha - Article · 05/15 09:29

Industry

Pharmaceuticals
+0.58%
Pharmaceuticals & Medical Research
+0.61%

Hot Stocks

Symbol
Price
%Change

About PETQ

PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.
More

Webull offers kinds of PetIQ Inc stock information, including NASDAQ:PETQ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PETQ stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PETQ stock methods without spending real money on the virtual paper trading platform.